| Secondary |
| Product Used For Unknown Indication |
23.5% |
| Hypertension |
17.6% |
| Essential Hypertension |
11.8% |
| Alveolitis |
5.9% |
| Cerebral Infarction |
5.9% |
| Hyperlipidaemia |
5.9% |
| Nephrotic Syndrome |
5.9% |
| Psoriatic Arthropathy |
5.9% |
| Arthralgia |
2.9% |
| Cardiac Failure |
2.9% |
| Diabetes Mellitus |
2.9% |
| Diabetic Nephropathy |
2.9% |
| Hyperphosphataemia |
2.9% |
| Infarction |
2.9% |
|
| Rhabdomyolysis |
12.9% |
| Completed Suicide |
9.7% |
| Vomiting |
9.7% |
| Angioedema |
6.5% |
| Pulmonary Oedema |
6.5% |
| Renal Failure Acute |
6.5% |
| Renal Impairment |
6.5% |
| Blood Potassium Increased |
3.2% |
| Cerebrovascular Accident |
3.2% |
| Hyperkalaemia |
3.2% |
| Laryngeal Oedema |
3.2% |
| Metabolic Acidosis |
3.2% |
| Muscle Spasms |
3.2% |
| Neutropenia |
3.2% |
| Pancreatitis |
3.2% |
| Peripheral Arterial Occlusive Disease |
3.2% |
| Protein Urine Present |
3.2% |
| Small Bowel Angioedema |
3.2% |
| Syncope |
3.2% |
| Weight Increased |
3.2% |
|
| Concomitant |
| Hypertension |
32.7% |
| Type 2 Diabetes Mellitus |
19.3% |
| Diabetes Mellitus |
11.2% |
| Product Used For Unknown Indication |
7.6% |
| Coronary Artery Disease |
3.5% |
| Colorectal Cancer Metastatic |
3.1% |
| Hyperlipidaemia |
2.8% |
| Prophylaxis |
2.6% |
| Drug Use For Unknown Indication |
2.4% |
| Embolic Stroke |
2.0% |
| Pain |
1.9% |
| Atrial Fibrillation |
1.5% |
| Cardiovascular Disorder |
1.4% |
| Osteoporosis |
1.4% |
| Renal Transplant |
1.4% |
| Depression |
1.2% |
| Stent Placement |
1.1% |
| Trigeminal Neuralgia |
1.1% |
| Cardiac Failure |
0.9% |
| Hypercholesterolaemia |
0.9% |
|
| Renal Failure |
15.7% |
| Orthostatic Intolerance |
7.4% |
| Vomiting |
6.5% |
| Hypotension |
5.6% |
| Blood Glucose Increased |
4.6% |
| Cerebrovascular Accident |
4.6% |
| Death |
4.6% |
| Hypertension |
4.6% |
| Hypoglycaemia |
4.6% |
| Urine Albumin/creatinine Ratio Increased |
4.6% |
| Blood Creatinine Increased |
3.7% |
| Cerebral Haemorrhage |
3.7% |
| Drug Ineffective |
3.7% |
| Fatigue |
3.7% |
| Glycosylated Haemoglobin Increased |
3.7% |
| Haemorrhagic Infarction |
3.7% |
| Histiocytosis |
3.7% |
| Oedema Peripheral |
3.7% |
| Prostate Cancer |
3.7% |
| Pyrexia |
3.7% |
|
| Interacting |
| Product Used For Unknown Indication |
96.3% |
| Hypertension |
1.9% |
| Post Herpetic Neuralgia |
1.9% |
|
| Drug Interaction |
66.7% |
| Shock |
33.3% |
|
